Orthopedic Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Implants, Instruments), By Services, By Region, And Segment Forecasts, 2024 - 2030

Orthopedic Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Implants, Instruments), By Services, By Region, And Segment Forecasts, 2024 - 2030


Orthopedic Contract Manufacturing Market Growth & Trends

The global orthopedic contract manufacturing market size is anticipated to reach USD 12.96 billion by 2030 and it is projected to grow at a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in off-shoring medical device manufacturing to the emerging economies, growing incidence of orthopedic conditions, technological advancements in orthopedic implants, and increasing pipeline products are few of the factors supporting the demand for contract manufacturing services, thereby augmenting the growth of the global market.

Technological innovations in orthopedic devices and implants have significantly transformed the landscape of musculoskeletal healthcare, enhancing patient outcomes and revolutionizing treatment approaches. Technological advancements such as 3D printing, advanced alloys, minimally invasive techniques, and nanotechnology applications are some parameters boosting demand for orthopedic products. Several medical device companies are focusing on the development of such novel products.

For instance, in April 2022, The Orthopaedic Implant Company announced the FDA clearance of its high-value dorsal spanning plate. This latest inclusion in the company’s orthopedic trauma implant lineup extends the potential clinical benefits of the DRPx wrist fracture plating system, solidifying its position as the most comprehensive and cost-effective alternative to other premium-priced plating systems. Hence, in response to meeting these demands, several original equipment manufacturers are collaborating with contract manufacturers to fast-track the development and manufacturing of these products, thus supporting market growth.

Furthermore, increasing patient demand for personalized and customized orthopedic implants, tailored to patient-specific anatomy and requirements is driving the need for third-party vendors with specialized expertise to manufacture such products. Moreover, the surge in orthopedic conditions such as osteoarthritis, bone fractures, and traumas has further boosted demand for bone health products, thereby supporting the growth of the global market.

Orthopedic Contract Manufacturing Market Report Highlights
  • Based on type, the implants segment dominated the market with a 63.5% revenue share in 2023. This large share is attributed to the increasing demand for novel orthopedic implants and increasing regulatory clearance of such products
  • Based on service, the spine & trauma segment is expected to grow at the fastest CAGR over the forecast period. The high growth of the segment is majorly due to the advancements in materials and technologies used to develop such products, which provide superior health benefits. This has resulted in a high number of product launches in this segment, thus simultaneously boosting demand for contract manufacturing services
  • North America dominated the market owing to factors such as increasing prevalence of orthopedic conditions in the region, presence of major market players, availability of reimbursement, and government support for quality healthcare
  • Asia Pacific is anticipated to witness a lucrative CAGR across the analysis timeframe. High growth of the region is majorly due to the presence of a vast and diverse patient population, increasing healthcare investments, favorable economic conditions, and a rising trend of outsourcing manufacturing processes have contributed to the emergence of the Asia-Pacific region as a key hub for high market growth
Please note The report will be delivered in 4-6 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Information or Data Analysis
1.6.1. Data analysis models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity flow analysis (Model 1)
1.8.2. Approach 1: Commodity flow approach
1.8.3. Parent Market Analysis (Model 2)
1.8.4. Approach 2: Parent Market Analysis
1.9. List of Secondary Sources
1.10. List of Primary Sources
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Orthopedic Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological innovations across orthopedic products
3.2.1.2. Rising incidence of orthopedic surgeries
3.2.1.3. Cost efficiency and outsourcing trends
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. High Initial Capital Investment
3.3. Orthopedic Contract Manufacturing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Orthopedic Contract Manufacturing Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Orthopedic Contract Manufacturing Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Implants
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Cases
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Trays
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Orthopedic Contract Manufacturing Market: Services Estimates & Trend Analysis
5.1. Services Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Orthopedic Contract Manufacturing Market by Services Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Forging/Casting
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Hip Machining & Finishing
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Knee Machining & Finishing
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Spine & Trauma
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Instrument Machining & Finishing
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Orthopedic Contract Manufacturing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Sweden
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Denmark
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. Thailand
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company/Competition Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2023
7.2. Company Profiles
7.2.1. Tecomet, Inc
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product/service benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Orchid Orthopedic Solutions
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product/service benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Cretex companies
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product/service benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Viant
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product/service benchmarking
7.2.4.4. Strategic initiatives
7.2.5. ARCH Medical Solutions Corp.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product/service benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Avalign Technologies
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product/service benchmarking
7.2.6.4. Strategic initiatives
7.2.7. LISI Medical
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product/service benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Paragon Medical
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product/service benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Norman Noble, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product/service benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Autocam Medical
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product/service benchmarking
7.2.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings